CN2 VALUE-FOR-MONEY OF PEMETREXED PLUS CISPLATIN VERSUS CISPLATIN ALONE IN THE TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA
May 1, 2005, 00:00 AM
10.1016/S1098-3015(10)62575-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)62575-2/fulltext
Section Title :
Section Order :
12
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62575-2&doi=10.1016/S1098-3015(10)62575-2